134 related articles for article (PubMed ID: 21609230)
1. Current Clinical Trials in Dry AMD and the Definition of Appropriate Clinical Outcome Measures.
Yehoshua Z; Rosenfeld PJ; Albini TA
Semin Ophthalmol; 2011 May; 26(3):167-80. PubMed ID: 21609230
[TBL] [Abstract][Full Text] [Related]
2. Current treatment of age-related macular degeneration.
Zarbin M; Szirth B
Optom Vis Sci; 2007 Jul; 84(7):559-72. PubMed ID: 17632299
[TBL] [Abstract][Full Text] [Related]
3. Update on current and future novel therapies for dry age-related macular degeneration.
Leung E; Landa G
Expert Rev Clin Pharmacol; 2013 Sep; 6(5):565-79. PubMed ID: 23971874
[TBL] [Abstract][Full Text] [Related]
4. Current therapeutic developments in atrophic age-related macular degeneration.
Hanus J; Zhao F; Wang S
Br J Ophthalmol; 2016 Jan; 100(1):122-7. PubMed ID: 26553922
[TBL] [Abstract][Full Text] [Related]
5. [Dry macular degeneration and embryonic stem cells ].
Nau JY
Rev Med Suisse; 2011 Feb; 7(280):322-3. PubMed ID: 21381277
[No Abstract] [Full Text] [Related]
6. Challenges in the Development of Therapy for Dry Age-Related Macular Degeneration.
Wei CX; Sun A; Yu Y; Liu Q; Tan YQ; Tachibana I; Zeng H; Wei JY
Adv Exp Med Biol; 2016; 854():103-9. PubMed ID: 26427400
[TBL] [Abstract][Full Text] [Related]
7. Clinical studies to implement Rheopheresis for age-related macular degeneration guided by evidence-based-medicine.
Klingel R; Fassbender C; Fassbender T; Göhlen B
Transfus Apher Sci; 2003 Aug; 29(1):71-84. PubMed ID: 12877897
[TBL] [Abstract][Full Text] [Related]
8. Spectral domain optical coherence tomography imaging of dry age-related macular degeneration.
Yehoshua Z; Rosenfeld PJ; Gregori G; Penha F
Ophthalmic Surg Lasers Imaging; 2010; 41 Suppl():S6-S14. PubMed ID: 21117603
[TBL] [Abstract][Full Text] [Related]
9. The role of complement membrane attack complex in dry and wet AMD - From hypothesis to clinical trials.
Kumar-Singh R
Exp Eye Res; 2019 Jul; 184():266-277. PubMed ID: 31082363
[TBL] [Abstract][Full Text] [Related]
10. Update on Clinical Trials in Dry Age-related Macular Degeneration.
Taskintuna I; Elsayed ME; Schatz P
Middle East Afr J Ophthalmol; 2016; 23(1):13-26. PubMed ID: 26957835
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic benefits of infrared (810-nm) diode laser macular grid photocoagulation in prophylactic treatment of nonexudative age-related macular degeneration: two-year results of a randomized pilot study.
Olk RJ; Friberg TR; Stickney KL; Akduman L; Wong KL; Chen MC; Levy MH; Garcia CA; Morse LS
Ophthalmology; 1999 Nov; 106(11):2082-90. PubMed ID: 10571341
[TBL] [Abstract][Full Text] [Related]
12. Breakthrough in dry version of macular degeneration. Discovery of biological pathway may lead to cure for dry AMD.
Duke Med Health News; 2012 Jul; 18(7):3. PubMed ID: 22872905
[No Abstract] [Full Text] [Related]
13. Report From the NEI/FDA Endpoints Workshop on Age-Related Macular Degeneration and Inherited Retinal Diseases.
Csaky K; Ferris F; Chew EY; Nair P; Cheetham JK; Duncan JL
Invest Ophthalmol Vis Sci; 2017 Jul; 58(9):3456-3463. PubMed ID: 28702674
[No Abstract] [Full Text] [Related]
14. Imaging characteristics of dry age-related macular degeneration.
Sohrab MA; Smith RT; Fawzi AA
Semin Ophthalmol; 2011 May; 26(3):156-66. PubMed ID: 21609229
[TBL] [Abstract][Full Text] [Related]
15. Emixustat and Lampalizumab: Potential Therapeutic Options for Geographic Atrophy.
Jack LS; Sadiq MA; Do DV; Nguyen QD
Dev Ophthalmol; 2016; 55():302-9. PubMed ID: 26501510
[TBL] [Abstract][Full Text] [Related]
16. Complement inhibition as a therapeutic strategy in retinal disorders.
Kassa E; Ciulla TA; Hussain RM; Dugel PU
Expert Opin Biol Ther; 2019 Apr; 19(4):335-342. PubMed ID: 30686077
[TBL] [Abstract][Full Text] [Related]
17. Effects of vitrectomy on age-related macular degeneration.
Roller AB; Mahajan VB; Boldt HC; Abramoff MD; Russell SR; Folk JC
Ophthalmology; 2010 Jul; 117(7):1381-6. PubMed ID: 20176401
[TBL] [Abstract][Full Text] [Related]
18. Natural history of predominantly classic, minimally classic, and occult subgroups in exudative age-related macular degeneration.
Shah AR; Del Priore LV
Ophthalmology; 2009 Oct; 116(10):1901-7. PubMed ID: 19592101
[TBL] [Abstract][Full Text] [Related]
19. Emerging treatments for geographic atrophy in age-related macular degeneration.
Mahmoudzadeh R; Hinkle JW; Hsu J; Garg SJ
Curr Opin Ophthalmol; 2021 May; 32(3):294-300. PubMed ID: 33630787
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and significance of subretinal drusenoid deposits (reticular pseudodrusen) in age-related macular degeneration.
Zweifel SA; Imamura Y; Spaide TC; Fujiwara T; Spaide RF
Ophthalmology; 2010 Sep; 117(9):1775-81. PubMed ID: 20472293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
